BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15893736)

  • 1. Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells.
    Byun HM; Suh D; Jeong Y; Wee HS; Kim JM; Kim WK; Ko JJ; Kim JS; Lee YB; Oh YK
    Biochem Biophys Res Commun; 2005 Jul; 332(2):518-23. PubMed ID: 15893736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene.
    Running Deer J; Allison DS
    Biotechnol Prog; 2004; 20(3):880-9. PubMed ID: 15176895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
    Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
    Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
    Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
    Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
    Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced transgene expression in the mouse skeletal muscle infected by the adeno-associated viral vector with the human elongation factor 1alpha promoter and a human chromatin insulator.
    Mori-Uchino M; Takeuchi T; Murakami I; Yano T; Yasugi T; Taketani Y; Nakagawa K; Kanda T
    J Gene Med; 2009 Jul; 11(7):598-604. PubMed ID: 19399759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
    Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
    Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
    Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
    Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation.
    Zeng X; Chen J; Sanchez JF; Coggiano M; Dillon-Carter O; Petersen J; Freed WJ
    Stem Cells; 2003; 21(6):647-53. PubMed ID: 14595124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo electroporation and ubiquitin promoter--a protocol for sustained gene expression in the lung.
    Gazdhar A; Bilici M; Pierog J; Ayuni EL; Gugger M; Wetterwald A; Cecchini M; Schmid RA
    J Gene Med; 2006 Jul; 8(7):910-8. PubMed ID: 16685743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CMV promoter-driven exogenous gene expression with doxorubicin in genetically modified cells.
    Kinoshita A; Kobayashi D; Hibino Y; Isago T; Uchino K; Yagi K; Hirai M; Saitoh Y; Komada F
    J Pharm Pharmacol; 2008 Dec; 60(12):1659-65. PubMed ID: 19000371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
    Kachi S; Esumi N; Zack DJ; Campochiaro PA
    Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery.
    Orbán TI; Apáti A; Németh A; Varga N; Krizsik V; Schamberger A; Szebényi K; Erdei Z; Várady G; Karászi E; Homolya L; Német K; Gócza E; Miskey C; Mátés L; Ivics Z; Izsvák Z; Sarkadi B
    Stem Cells; 2009 May; 27(5):1077-87. PubMed ID: 19415778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.
    Teschendorf C; Warrington KH; Siemann DW; Muzyczka N
    Anticancer Res; 2002; 22(6A):3325-30. PubMed ID: 12530082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizations of Hirudo medicinalis DNA promoters for targeted gene expression.
    Baker MW; Macagno ER
    J Neurosci Methods; 2006 Sep; 156(1-2):145-53. PubMed ID: 16621015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro search for alternative promoters to the human immediate early cytomegalovirus (IE-cMV) to express the G gene of viral haemorrhagic septicemia virus (VHSV) in fish epithelial cells.
    Ruiz S; Tafalla C; Cuesta A; Estepa A; Coll JM
    Vaccine; 2008 Dec; 26(51):6620-9. PubMed ID: 18840493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
    Liu BH; Yang Y; Paton JF; Li F; Boulaire J; Kasparov S; Wang S
    Mol Ther; 2006 Dec; 14(6):872-82. PubMed ID: 16904943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific monitoring of cardiomyogenic and endothelial differentiation by dual promoter-driven reporter systems in bone marrow mesenchymal stem cells.
    Choi SC; Shim WJ; Lim DS
    Biotechnol Lett; 2008 May; 30(5):835-43. PubMed ID: 18175067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable transgene expression in human embryonic stem cells after simple chemical transfection.
    Liu J; Jones KL; Sumer H; Verma PJ
    Mol Reprod Dev; 2009 Jun; 76(6):580-6. PubMed ID: 19034957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct.
    Curtin JA; Dane AP; Swanson A; Alexander IE; Ginn SL
    Gene Ther; 2008 Mar; 15(5):384-90. PubMed ID: 18283290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.